Boston Business Journal - by Julie M. Donnelly
ConforMIS Inc. announced today that its customizable knee-replacement product has been approved by European regulators.
The privately held company said its iUni G2 system is a one-of-its-kind implant that provides an alternative to total knee replacements, which may remove healthy tissue in the process. The orthopedic implants designed by ConforMIS are built to match scans of an individual’s knee.
The device is already approved in the United States.
The Burlington, Mass-based company, which develops and commercializes medical devices for osteoarthritis treatment and joint damage, was founded in 2004. The company raised $50 million in July from private equity and sovereign wealth funds in the United States, Europe, Asia and the Middle East. Aeris Capital has invested the most funds in the company to date.